Previous close | 232.02 |
Open | 232.33 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 231.77 - 233.07 |
52-week range | 154.10 - 233.07 |
Volume | |
Avg. volume | 7,518 |
Market cap | 662.192M |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | 0.61 |
EPS (TTM) | 3.84 |
Earnings date | 30 July 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.
Veeva System's (VEEV) strong product demand and strategic deals raise optimism about the stock.
GE HealthCare (GEHC) and Medis Medical collaborate to boost precision care for coronary artery disease treatment.